Your browser is no longer supported. Please, upgrade your browser.
Settings
PBYI Puma Biotechnology, Inc. daily Stock Chart
PBYI [NASD]
Puma Biotechnology, Inc.
Index- P/E- EPS (ttm)-8.29 Insider Own11.60% Shs Outstand36.56M Perf Week4.07%
Market Cap1.40B Forward P/E- EPS next Y-4.64 Insider Trans-0.49% Shs Float31.80M Perf Month-3.40%
Income-276.00M PEG- EPS next Q-1.96 Inst Own96.80% Short Float25.37% Perf Quarter17.46%
Sales- P/S- EPS this Y-11.30% Inst Trans0.00% Short Ratio8.27 Perf Half Y-11.94%
Book/sh5.88 P/B6.52 EPS next Y44.20% ROA-144.70% Target Price68.67 Perf Year17.28%
Cash/sh6.28 P/C6.11 EPS next 5Y- ROE-186.20% 52W Range19.74 - 73.27 Perf YTD24.92%
Dividend- P/FCF- EPS past 5Y-44.40% ROI- 52W High-47.66% Beta0.46
Dividend %- Quick Ratio6.30 Sales past 5Y- Gross Margin- 52W Low94.28% ATR2.13
Employees160 Current Ratio6.30 Sales Q/Q- Oper. Margin- RSI (14)53.64 Volatility3.54% 5.93%
OptionableYes Debt/Eq0.00 EPS Q/Q-7.00% Profit Margin- Rel Volume0.61 Prev Close37.30
ShortableYes LT Debt/Eq0.00 EarningsMay 31 AMC Payout- Avg Volume975.28K Price38.35
Recom1.90 SMA204.06% SMA501.05% SMA200-11.30% Volume597,283 Change2.82%
Mar-02-17Reiterated RBC Capital Mkts Sector Perform $48 → $17
Sep-22-16Reiterated Credit Suisse Outperform $54 → $111
Sep-21-16Upgrade Stifel Hold → Buy $61 → $88
Mar-29-16Downgrade RBC Capital Mkts Outperform → Sector Perform $103 → $36
Jan-21-16Initiated Credit Suisse Outperform
Dec-14-15Upgrade Citigroup Neutral → Buy
Sep-03-15Initiated Citigroup Neutral
Aug-27-15Initiated JP Morgan Overweight $122
Jan-23-15Initiated RBC Capital Mkts Outperform $282
Aug-19-14Resumed Stifel Hold
Jul-23-14Reiterated UBS Buy $125 → $325
Dec-19-13Reiterated UBS Buy $61 → $125
Dec-19-13Downgrade Stifel Buy → Hold
Jul-22-13Reiterated Stifel Buy $42 → $64
Jun-03-13Reiterated UBS Buy $35 → $49
Mar-25-13Reiterated Stifel Buy $32 → $42
Mar-20-13Reiterated UBS Buy $27 → $35
Apr-18-17 01:31PM  Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug TheStreet.com -6.94%
Apr-17-17 08:03AM  Puma Biotechnology Announces FDA Advisory Committee to Review Neratinib for the Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire +11.08%
Apr-04-17 01:05PM  Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 AACR Annual Meeting Business Wire
01:05PM  Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 AACR Annual Meeting
Apr-02-17 03:03PM  Puma Biotechnology Presents Interim Results of Phase Ib/II FB-10 Trial of PB272 in Combination with Trastuzumab Emtansine (T-DM1) in HER2-Positive Metastatic Breast Cancer at the 2017 AACR Annual Meeting Business Wire
11:03AM  Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of PB272 for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Cancer at the 2017 AACR Annual Meeting Business Wire
10:30AM  Puma Biotechnology Launches Expanded Access Program for PB272 (Neratinib) for U.S. Patients with HER2-Positive Breast Cancer or HER2-Mutated Cancers Business Wire
Mar-24-17 05:00PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and
Mar-20-17 01:00PM  Finding Bullish and Bearish Market Reversals TheStreet.com
01:00PM  Finding Bullish and Bearish Market Reversals
Mar-09-17 07:00AM  7 Stocks Trending Up With Monster Volume TheStreet.com
07:00AM  7 Stocks Trending Up With Monster Volume
Mar-08-17 04:26PM  Puma Leads Massive Biotech Surge As Esperion Hits 15-Month High Investor's Business Daily +13.20%
04:26PM  Puma Leads Massive Biotech Surge As Esperion Hits 15-Month High
Mar-07-17 01:04PM  PUMA BIOTECHNOLOGY, INC. Financials +5.79%
Mar-02-17 05:31PM  Kroger, Shake Shack and Puma dip; Monster Beverage gains Associated Press -13.80%
05:31PM  Kroger, Shake Shack and Puma dip; Monster Beverage gains
04:53PM  Puma (PBYI) Q4 Loss Wider than Expected, Neratinib in Focus Zacks
04:53PM  Puma (PBYI) Q4 Loss Wider than Expected, Neratinib in Focus
04:43PM  Why Puma Biotechnology Inc. Got Hammered Today at Motley Fool
04:20PM  Puma Biotechnology to Present at Cowens Health Care Conference Business Wire
12:05PM  Puma Plunges on Breast Cancer Drug Update at Investopedia
10:42AM  Top Biotech Stocks With FDA Decisions in 2017 at Motley Fool
09:14AM  Puma Biotech shares plummet 26% after Roche reports positive results for late-stage breast cancer drug at MarketWatch
06:36AM  Roche Shares Soar, Puma Bio Sinks on Perjeta Breast Cancer Study Win
Mar-01-17 06:08PM  Puma Biotech reports 4Q loss
06:02PM  Puma Biotechnology Announces Publication of Abstracts on Neratinib for the AACR Annual Meeting 2017 Business Wire
04:59PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:46PM  Puma Biotechnology Provides Update on Review of Marketing Authorisation Application for PB272 Business Wire
04:20PM  Puma Biotechnology Reports Fourth Quarter and Full Year 2016 Financial Results Business Wire
04:11PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 10-K, Annual Report
Feb-27-17 08:28AM  Puma Biotechnology (PBYI) Q4 Earnings: What's in the Cards?
Feb-14-17 04:15PM  Puma Biotechnology to Present at RBC Capital Markets Healthcare Conference Business Wire
Feb-08-17 04:15PM  Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference Business Wire +10.04%
Feb-03-17 09:19AM  Biotech Stock Mailbag: Do Investors Have an 'Aphinity' for Shorting Puma Into Trial Results?
Jan-09-17 06:07PM  Puma (PBYI) Expands Study Cohort for Lead Candidate PB272
04:55PM  Newman Ferrara LLP Announces Corporate Governance Investigation of Puma Biotechnology, Inc. - PBYI Business Wire
Jan-06-17 02:13PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events
08:15AM  Puma Biotechnology Expands Cohort in Phase II SUMMIT Trial of PB272 in HER2 Mutation-Positive Cancer Patients Business Wire
Jan-03-17 04:15PM  Puma Biotechnology to Present at J.P. Morgan Healthcare Conference Business Wire
Dec-19-16 04:27PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
04:15PM  Puma Biotechnology to Move Stock Exchange Listing to Nasdaq Business Wire
Dec-08-16 12:38PM  Puma Cancer Drug Suffers 'Approvability Risk' On Extreme Side Effect -8.42%
08:46AM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events
08:35AM  Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2016 San Antonio Breast Cancer Symposium Business Wire
Dec-07-16 06:21PM  Puma Biotechnology Presents Results of Biomarker Analysis of Phase II Trial of PB272 in Neoadjuvant Treatment of HER2-Positive Locally Advanced Breast Cancer at the 2016 San Antonio Breast Cancer Symposium Business Wire
06:07PM  Puma Biotechnology Presents Interim Results of Phase II Trial of PB272 for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2016 San Antonio Breast Cancer Symposium Business Wire
07:00AM  Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards
Dec-06-16 06:44PM  CORRECTING and REPLACING Puma Biotechnology Initiates a Managed Access Program for PB272 (Neratinib) Outside the United States Business Wire
Nov-30-16 09:33AM  Why Did Puma Biotechnology Dilute Shareholders? at Motley Fool
Nov-28-16 02:11PM  Puma Biotechnology, Inc. :PBYI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 -5.31%
Nov-22-16 08:12AM  Shareholder Dilution: What Investors Need to Know at Motley Fool
Nov-19-16 10:15AM  4 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Nov-15-16 03:57PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Puma Biotechnology, Inc. and Advises Investors with Losses to Contact the Firm Business Wire +7.36%
03:11PM  Heres Why The Puma Biotechnology Inc (PBYI) Pullback Might Be A Buy-In Opportunity at Insider Monkey
03:10PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Puma Biotechnology, Inc. (PBYI) PR Newswire
01:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI PR Newswire
Nov-14-16 07:16PM  Puma Biotechnology Announces Presentations of Investigational Data at the San Antonio Breast Cancer Symposium (SABCS) Business Wire -20.44%
05:36PM  What Caused Puma Biotechnology's Shares to Tumble 20.5% Today at Motley Fool
04:37PM  Credit Suisse Says Gr3 Diarrhea Still A Concern For Puma Biotech, But Pullback Is Overdone
01:13PM  Puma Biotechnology falls more than 20% at CNBC
11:25AM  Puma Bio Falls on Escalating Concerns About Diarrhea Risk With Breast Cancer Drug
Nov-11-16 10:07PM  Puma Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI PR Newswire
Nov-10-16 07:50AM  Puma (PBYI) Posts Wider Loss in Q3, Neratinib in Focus
Nov-09-16 05:29PM  Puma Biotech reports 3Q loss +16.25%
05:24PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:15PM  Puma Biotechnology Reports Third Quarter 2016 Financial Results Business Wire
04:11PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 10-Q, Quarterly Report
Nov-03-16 06:24PM  Puma Biotechnology (PBYI) Q3 Earnings: What's in Store? -9.31%
Oct-31-16 04:15PM  Puma Biotechnology to Present at Credit Suisse Healthcare Conference Business Wire
11:38AM  Lifshitz & Miller Law Firm Announces Investigation of Electronics for Imaging, Inc., Ferrellgas Partners LP, Fusion Pharm, Inc., Humana Inc., KemPharm, Inc., National Beverage Corp., Puma Biotechnology, Inc., and TG Therapeutics, Inc. PR Newswire
Oct-28-16 10:07PM  PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. PBYI Business Wire
Oct-25-16 11:45AM  Puma Biotechnology Closes $172 Million Public Offering of Common Stock Business Wire
Oct-23-16 10:15AM  4 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Oct-21-16 05:04PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:34PM  Puma Biotech, Which Had Weak Demand For A Secondary Offering, Is Also Part Of The SEC Tick Size Pilot Program
08:31AM  Puma Biotechnology Announces Underwriters Full Exercise of Option to Purchase Additional Shares Business Wire
Oct-20-16 08:40AM  Puma Bio's Desperate Money Grab Signals Breast Cancer Drug Trouble
04:43AM  Ups And Downs In Biotech This Week: PTC Therapeutics, Inc. (PTCT), Puma Biotechnology Inc (PBYI) and Nektar Therapeutics (NKTR) at Insider Monkey
Oct-19-16 11:18PM  Puma Biotechnology Prices Public Offering of Common Stock Business Wire -18.90%
03:43PM  Puma Biotech Gears Up for Secondary Offering
01:01PM  Why Puma Biotechnology Inc. Sold Lower Today at Motley Fool
09:07AM  Why Traders Are Watching Manhattan Associates, Meridian Bioscience, Puma Biotechnology, Tesla and More at Insider Monkey
Oct-18-16 05:53PM  Puma Biotechnology (PBYI) Stock Down in After-Hours Trading on Public Offering
04:36PM  Puma Biotech shares slide on secondary stock offering at MarketWatch
04:15PM  Puma Biotechnology Announces Proposed Public Offering of Common Stock Business Wire
Oct-17-16 06:04AM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
Oct-14-16 10:07PM  PUMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. PBYI Business Wire
Oct-12-16 02:52PM  Robbins Arroyo LLP: Puma Biotechnology, Inc. (PBYI) Investors Survive Defendants' Motion to Dismiss in Securities Class Action Business Wire
Oct-11-16 11:30AM  Puma Biotechnology, Inc. Shareholder Alert: Schubert Firm Investigates Company's Top Executives PR Newswire
Oct-10-16 10:32AM  Johnson & Weaver, LLP Initiates Investigations of Puma Biotechnology, Inc., Virtus Investment Partners, Inc., AAC Holdings, Inc. and Spectrum Pharmaceuticals, Inc.; Encourages Long-Term Investors to Contact the Firm Regarding Their Legal Ri PR Newswire
Oct-04-16 10:15AM  Lawsuit for Investors in shares of Puma Biotechnology Inc (NYSE:PBYI) against Directors announced by Shareholders Foundation GlobeNewswire
Sep-30-16 09:13AM  5 Top Performing Stocks of the Best ETF of Q3
09:10AM  SEC Issues Charges Over Biotech Insider Activity
07:00AM  Biotech Stock Mailbag: Dynavax, Puma, Ariad
Sep-29-16 04:05PM  SEC charges former Puma Biotech employee with insider trading Reuters
Sep-27-16 11:49AM  Momentum Carries Lululemon Lower, Pushes Biotech Names Higher at Forbes
Sep-25-16 10:45AM  6 Biotech and Biohealth Analyst Picks for 50% to 150% Upside at 24/7 Wall St.
10:20AM  Could Puma Biotech Double After This FDA Approval? at 24/7 Wall St.
Sep-22-16 04:31PM  Puma Races To Eight-Month High On Breast Cancer Drug Success
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care. Its drug candidates include PB272 (neratinib (oral)) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 (neratinib (intravenous)). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHARNAS ROBERTFeb 01Sale31.833,00895,75526,453Feb 02 05:43 PM
Lo StevenChief Commercial OfficerJan 20Sale33.242,29076,10829,210Jan 24 05:56 PM
EYLER CHARLES RSEE REMARKSJan 20Sale33.2482027,2539,680Jan 24 05:53 PM
CHARNAS ROBERTJan 20Sale33.242,29376,20829,407Jan 24 05:52 PM
BRYCE RICHARD PAULSR VP, CLINICAL RESEARCH & DEVJan 20Sale33.242,29376,20829,237Jan 24 05:51 PM
AUERBACH ALAN HPRESIDENT AND CEOJan 20Sale33.2410,202339,0644,179,798Jan 24 05:49 PM
SOXL Direxion Daily Semicondct Bull 3X ETF daily Stock Chart
SOXL [NYSE]
Direxion Daily Semicondct Bull 3X ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week12.95%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month3.48%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter24.55%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.24 Perf Half Y78.68%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year211.47%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range21.10 - 79.89 Perf YTD38.88%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-0.74% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low275.83% ATR3.06
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)62.52 Volatility3.18% 3.69%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.94 Prev Close76.90
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume306.86K Price79.30
Recom- SMA207.00% SMA508.41% SMA20044.92% Volume287,458 Change3.12%
Apr-17-17 01:16PM  These Are The Hot Leveraged Sector ETFs Heading Into This Week Benzinga
Apr-04-17 10:38AM  Which Sectors Are Likely to Outperform in the Short Term? Market Realist
10:38AM  Which Sectors Are Likely to Outperform in the Short Term?
09:02AM  How Trumps Proposed Policies Have Caused Sector Divergence Market Realist
09:02AM  How Trumps Proposed Policies Have Caused Sector Divergence
Mar-31-17 12:11PM  5 Best Performing Inverse/Leveraged ETFs of March Zacks
12:11PM  5 Best Performing Inverse/Leveraged ETFs of March
Jan-03-17 10:53AM  Top 5 Semiconductor ETFs of 2016 Investopedia
10:53AM  Top 5 Semiconductor ETFs of 2016 at Investopedia
Dec-28-16 02:07PM  6 Best Performing Leveraged ETFs of 2016 Zacks -5.81%
02:07PM  6 Best Performing Leveraged ETFs of 2016
Nov-22-16 09:27AM  Bull Market Here to Stay: 10 ETF Ways to Play Zacks
09:27AM  Bull Market Here to Stay: 10 ETF Ways to Play
Oct-04-16 12:15AM  Best and Worst Performing ETFs of Q3 2016 (SOXL, LABU) Investopedia
12:15AM  Best and Worst Performing ETFs of Q3 2016 (SOXL, LABU) at Investopedia
Oct-03-16 10:58AM  5 Best Performing Leveraged ETFs of September Zacks
10:58AM  5 Best Performing Leveraged ETFs of September
Aug-08-16 05:09PM  How Volatility Affects 2 Popular Leveraged ETFs Benzinga
05:09PM  How Volatility Affects 2 Popular Leveraged ETFs
Jul-22-16 08:16AM  A Rocking Russia ETF
Jul-19-16 01:35PM  Loving Leveraged Bond ETFs
Jul-18-16 01:56PM  SoftBank, ARM Deal Helps Semiconductor ETF Push Higher
Jun-30-16 01:26PM  A Brexit Boon For These Leveraged ETFs +5.45%
Jun-16-16 01:45PM  Listen To What Leveraged S&P 500 ETFs Are Saying
Jun-10-16 09:21AM  A Conservative Way To Short The S&P 500 -5.02%
May-31-16 01:59PM  Suddenly Super Semiconductor ETFs; But Is It A Home Run?
May-27-16 01:11PM  This Biotech ETF Could Be Ready To Party
May-20-16 01:52PM  Applied Materials Earnings Beat Helps Semiconductor ETFs Power Up +9.31%
01:30PM  ETF TMI: Latest ETF Launches, Transitions & Jumps
10:54AM  Monitoring Oil Services ETFs Schlumberger, Halliburton
10:51AM  If Rates Rise, Look to These Junk Bond ETFs
10:46AM  Amazon, Wal-Mart Will Lift This Retail ETF
10:40AM  Corn ETF Looks to Breakout
10:34AM  Steady Swiss ETFs Ready to Rally
08:25AM  Bank on Financial ETFs in Rising Rate Environment
08:15AM  Getting Tactical for the Long Term
May-19-16 04:26PM  41 Target Maturity Bond ETFs for Rising Rates
May-18-16 08:20AM  Dollar ETFs Look for Green
May-08-16 12:25PM  USD vs. SOXL: Comparing Leveraged Semiconductor ETFs at Investopedia
Apr-22-16 05:51AM  Gold Miner ETFs Are Having the Rally of a Lifetime and Burned Investors Are Missing It at Bloomberg
Apr-12-16 08:15AM  Leveraged Energy ETFs For Earnings Season
Apr-08-16 08:41AM  New Inverse ETFs For Bearish Sector Traders
Mar-23-16 01:45AM  How To Trade Leveraged ETFs
Mar-17-16 07:27AM  Rousseff Is A Problem For Brazil Leveraged ETF
Mar-08-16 08:11AM  Brazil ETF's Rise Stokes Volume Spike In Leveraged Counterpart -6.81%
Mar-02-16 01:58PM  These Bond ETFs Are On Fire
01:04PM  The strange ETF thats doubled this year at CNBC
Feb-26-16 03:03PM  Some Say The Gold Miners Trade Is Back
Feb-12-16 08:11AM  This Little Nugget Of An ETF Is Delivering Astounding Returns +6.61%
Feb-04-16 01:19PM  Leveraged Miners ETF Struts Its Stuff
Jan-29-16 08:34AM  Gold Miner ETFs Rake In Assets Despite Dismal Performance +13.50%
Jan-26-16 06:47AM  Traders Are Missing Out On The Right China ETFs
Jan-20-16 02:03PM  6 Inverse Leveraged ETFs Up Over 50% YTD
Jan-12-16 09:30AM  The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear
Jan-11-16 10:18AM  6 Inverse Leveraged ETFs Soaring to Start 2016
06:14AM  Traders Aren't Displaying Much Confidence In Leveraged Gold Miner ETFs
Dec-22-15 07:56AM  Russia ETFs On The Rocks...Except For One
Dec-11-15 09:36AM  Using Leveraged Energy ETFs As Rising Rates Plays -5.88%
Dec-03-15 02:17PM  A New Bearish Biotech ETF And A Lazarus Act For A Couple Leveraged Funds
Nov-23-15 01:52PM  The One Retail ETF That Isn't Disappointing
Nov-21-15 02:02PM  Russia Rally Reveals Love For Leverage
Nov-18-15 03:50PM  Gold Miners ETFs Are Getting Smoked
Nov-10-15 06:28AM  Digging Deep With Leveraged Gold Miner ETFs As Higher Rates Loom -5.44%
Nov-09-15 02:58PM  Rate Hike Odds Shine A Light On Leveraged Gold Miners ETFs
Oct-15-15 07:46AM  Here's How Traders Have Once Again Botched The Gold Miners Trade
Oct-13-15 09:30AM  The Zacks Analyst Blog Highlights: ERX,DIG,GASL,GUSH and UOP
07:15AM  How To Use Leveraged ETFs To Beat The Fed
Oct-09-15 12:06AM  Bill Gross Believes Every Asset Price Is Artificially Elevated
Oct-05-15 02:26PM  Bullish Leveraged Gold Miners ETFs Are On Fire +5.57%
Sep-28-15 03:57PM  Wild Ride For Leveraged Biotech ETFs Continues -8.34%
Sep-15-15 03:43PM  Not DUST In The Wind: Perhaps The Best Gold Miners ETF
Aug-26-15 01:02PM  Traders Are Getting It Wrong With Leveraged Emerging Markets ETFs +14.85%
Aug-21-15 02:43PM  The Right ETF For Russia Right Now -7.08%
Aug-14-15 03:29PM  Well Look At That: Gold Miners ETFs Try To Bounce Back
Aug-11-15 03:31PM  Dancing With The Devil: Looking For Bottoms With Leveraged Bull Energy ETFs -6.80%
Aug-10-15 07:03AM  Leveraged Gold Miners ETFs To Host Reverse Split Party +7.50%
Aug-07-15 05:29PM  Direxion Announces ETF Splits: 3X Bullish Gold Miners to See 1-for-10 Reverse at Barrons.com
Aug-05-15 03:42PM  For The Bold: Bearish Energy ETF Ideas
Aug-04-15 09:30AM  The Zacks Analyst Blog Highlights: Direxion Daily Gold Miners Index Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, Direxion Daily Junior Gold Miners Index Bear 3x Shares and ProShares UltraShort Gold Miners ETF - Press Releases
Jul-28-15 10:00AM  Enter the Bear: How to Win With ETFs as Chinese Stocks Tumble at TheStreet +6.23%
Jul-27-15 10:03AM  A Look Ahead: Biotech And Energy ETFs To Watch This Week
May-20-15 01:17PM  Processing a Leveraged ETF Trade Idea
Mar-30-15 02:00PM  Intel/Altera Rumor Stokes Inflows to Leveraged Chip ETF
Mar-27-15 02:16PM  Semiconductor ETFs Could See Further Pain
Dec-17-14 03:55PM  10 Best Leveraged ETFs of 2014
Sep-15-14 12:18PM  Semiconductors Selloff After Failed Breakout
Jul-15-14 02:22PM  Big Earnings Week for This Semiconductor ETF
May-27-14 03:33PM  Leveraged ETF Roundup: Russia, India & Semiconductor Lead
May-15-14 03:47PM  How AMD's Market Share Can Rise To 30% After The MacPro Deal at Seeking Alpha
May-02-14 06:12PM  What To Expect From Qualcomm at Seeking Alpha
Apr-28-14 11:20AM  NXP's Buyback, Q1 Results And Sell Side Commentary at Seeking Alpha
Apr-25-14 03:12PM  Qualcomm's Revenue Growth Slows Amid Smartphone Saturation, Slow LTE Sales In China at Seeking Alpha
Apr-24-14 06:40PM  Remaining A Little Nervously Long Qualcomm at Seeking Alpha
Apr-22-14 04:19PM  Qualcomm Earnings Preview: Chipset And Device ASPs In Focus Amid High-End Saturation at Seeking Alpha
Apr-21-14 08:35PM  AMD: Now With Lower Risk And Greater Upside at Seeking Alpha
05:28PM  Intel Is Still Struggling In The PC And Mobile Chips Business at Seeking Alpha
Apr-17-14 04:24PM  Enterprise Storage Drives SanDisk's Q1 Results, Embedded Storage Could Follow Suit at Seeking Alpha
Apr-16-14 04:52PM  Micron Technology: Worth Between $29-33 Per Share, Strong Buy On Market Correction at Seeking Alpha
Apr-15-14 05:10PM  Enterprise Storage To Drive SanDisk's First Quarter Performance at Seeking Alpha
Apr-09-14 05:13PM  AMD: The New Puma Chip As A Catalyst In Mobile at Seeking Alpha
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the PHLX Semiconductor Sector Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index measures the performance of domestic companies engaged in the design, distribution, manufacture and sale of semiconductors. The fund is non-diversified.
ABCO The Advisory Board Company daily Stock Chart
ABCO [NASD]
The Advisory Board Company
Index- P/E20.93 EPS (ttm)2.25 Insider Own1.10% Shs Outstand40.02M Perf Week0.11%
Market Cap1.88B Forward P/E22.10 EPS next Y2.13 Insider Trans-23.85% Shs Float39.66M Perf Month5.15%
Income91.20M PEG1.45 EPS next Q0.37 Inst Own- Short Float6.28% Perf Quarter8.17%
Sales803.40M P/S2.34 EPS this Y178.60% Inst Trans5.22% Short Ratio4.11 Perf Half Y10.33%
Book/sh12.87 P/B3.65 EPS next Y11.36% ROA4.70% Target Price47.18 Perf Year49.35%
Cash/sh2.28 P/C20.62 EPS next 5Y14.46% ROE19.70% 52W Range24.85 - 51.23 Perf YTD41.35%
Dividend- P/FCF29.34 EPS past 5Y27.60% ROI5.90% 52W High-8.26% Beta1.10
Dividend %- Quick Ratio1.00 Sales past 5Y16.80% Gross Margin51.10% 52W Low89.13% ATR0.92
Employees3800 Current Ratio1.00 Sales Q/Q0.10% Oper. Margin9.50% RSI (14)54.70 Volatility1.23% 1.64%
OptionableYes Debt/Eq1.13 EPS Q/Q135.00% Profit Margin11.40% Rel Volume0.44 Prev Close47.05
ShortableYes LT Debt/Eq1.04 EarningsMay 04 AMC Payout0.00% Avg Volume606.45K Price47.00
Recom2.30 SMA20-0.09% SMA501.69% SMA20013.78% Volume268,870 Change-0.11%
Mar-27-17Upgrade Robert W. Baird Neutral → Outperform $50 → $53
Mar-10-17Downgrade SunTrust Buy → Hold
Feb-17-17Downgrade JP Morgan Overweight → Neutral
Jan-31-17Reiterated Stifel Hold $38 → $47
Jan-13-17Downgrade Piper Jaffray Overweight → Neutral
Nov-07-16Downgrade BofA/Merrill Buy → Underperform
Nov-02-16Reiterated Stifel Hold $45 → $43
Sep-30-16Reiterated Barclays Overweight $44 → $50
Jul-28-16Upgrade Craig Hallum Hold → Buy
Jul-28-16Reiterated FBR Capital Mkt Perform $35 → $37
Jul-19-16Downgrade Raymond James Outperform → Mkt Perform
Jun-20-16Initiated Credit Suisse Outperform
May-06-16Reiterated FBR Capital Mkt Perform $40 → $35
Apr-18-16Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-25-16Upgrade Deutsche Bank Hold → Buy $53 → $43
Feb-24-16Downgrade Stifel Buy → Hold
Feb-24-16Downgrade Robert W. Baird Outperform → Neutral $60 → $40
Feb-24-16Downgrade FBR Capital Outperform → Mkt Perform $55 → $40
Feb-24-16Downgrade Craig Hallum Buy → Hold
Feb-24-16Downgrade Cantor Fitzgerald Buy → Hold
Apr-20-17 09:00AM  The Advisory Board Company to Report First Quarter Financial Results After Market Close on May 4, 2017 PR Newswire
Apr-06-17 04:42PM  Hospital Executives See Future Growth in Outpatient, Higher-Value Care, Survey Finds PR Newswire
Mar-27-17 05:15PM  Chances Of Advisory Board Getting Taken Out Just Got Considerably Higher Benzinga
10:24AM  Report: Evolent Health weighs merger with Advisory Board at bizjournals.com
10:24AM  Report: Evolent Health weighs merger with Advisory Board American City Business Journals
06:54AM  Advisory Board upgraded by Robert W. Baird
Mar-23-17 10:19AM  Allergan's Restasis Now Available in Multidose Bottle in U.S. Zacks
09:36AM  Ultragenyx's Seizure Candidate UX007 Fails in Phase II Study Zacks
08:13AM  The Advisory Board Co. breached its 50 day moving average in a Bearish Manner : ABCO-US : March 23, 2017 Capital Cube
Mar-22-17 01:04PM  ADVISORY BOARD CO Financials
Mar-21-17 10:54AM  Jazz Sleep Disorder Drug Positive in Phase III Studies
Mar-20-17 10:10AM  BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet Zacks
Mar-17-17 09:58AM  Teva Launches Authorized Generic of Allergan's Minastrin
Mar-16-17 11:20AM  Jazz Initiates Phase III Study for Narcolepsy Candidate Zacks
06:06AM  ADVISORY BOARD CO Files SEC form 10-K, Annual Report
Mar-15-17 03:47PM  AstraZeneca's Cancer Drug Lynparza Positive in Phase III
11:13AM  Community Health Continues Divestiture, to Sell 4 Hospitals Zacks
Mar-14-17 04:52PM  Teladoc Continues to Grow in Booming Telehealth Industry Zacks
01:33PM  Advisory Board fights off potential board takeover at bizjournals.com
08:15AM  Post Earnings Coverage as Priceline's Q4 Bottom-line Surged 32% Y-o-Y; Beat Forecasts Accesswire
Mar-06-17 03:07PM  Advisory Board and Elliott Management Reach a Standstill at Investopedia
Mar-03-17 05:24PM  Elliott Settles With Advisory Board as Strategic Review Continues at TheStreet
Mar-02-17 10:25AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017
Mar-01-17 04:01PM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:22AM  Edited Transcript of ABCO earnings conference call or presentation 28-Feb-17 10:30pm GMT
Feb-28-17 04:10PM  The Advisory Board Company Reports Fourth Quarter And Full-Year 2016 Results PR Newswire
07:07AM  Q4 2016 Advisory Board Co Earnings Release - After Market Close
Feb-23-17 09:45AM  [2/23] Today's Top 10 Long/Short Estimize Signal Scores
Feb-17-17 02:54PM  JPMorgan Doesn't Advise Buying Advisory Board, Despite 'Strategic Alternative' Talk
08:05AM  Analysts' Actions -- Arista, Capital One, Avis, Workday and More
Feb-09-17 04:36PM  These top 20 D.C.-area employers have most at stake in H-1B visa overhaul at bizjournals.com
Feb-08-17 12:43PM  [2/8] This Weeks Earnings Revisions Movers - Tech and Consumer Discretionary Lead
Feb-06-17 03:59PM  Activist-Pressured Advisory Board Launches Strategic Review
02:03PM  Advisory Board confirms it is evaluating a potential sale at bizjournals.com
08:35AM  ADVISORY BOARD CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  The Advisory Board Company Announces Exploration of Strategic Alternatives PR Newswire
Feb-03-17 09:13AM  The Market In 5 Minutes: Amazon Lower, Payrolls Higher
08:20AM  Report: Advisory Board interviewing banks for potential sale at bizjournals.com
Feb-02-17 02:47PM  Advisory Board Said to Interview Banks About Possible Sale
Feb-01-17 11:30AM  The Advisory Board Company to Report Fourth Quarter and Year-end Financial Results After Market Close on February 28, 2017 PR Newswire
09:56AM  McAuliffe confirms anchor lease with Nestlé in Rosslyn at bizjournals.com
Jan-28-17 12:01AM  [$$] Barron's Roundtable, Part 3: Digging Into the Details at Barrons.com
Jan-17-17 04:17PM  Paul Singer's Elliott Management Takes 8.3% Stake in Advisory Board at Investopedia
03:18PM  Advisory Board just laid off more than 200 people. What does this mean for its $60M in tax breaks? at bizjournals.com
01:27PM  Elliott 'Strategic Initiative' Effort at NRG Could Lead to Asset Sales, Buyout
Jan-13-17 10:39AM  Advisory Board Company (ABCO) Enters Overbought Territory
08:35AM  The Advisory Board (ABCO) in Focus: Stock Surges 16.2%
08:30AM  Activist investor buys stake in The Advisory Board Co. at bizjournals.com
Jan-12-17 01:31PM  Activist Paul Singer's Pressure Boosts Advisory Board Stock +16.18%
12:07PM  Why The Advisory Board Company Stock Jumped Today at Motley Fool
Jan-10-17 10:24AM  The Advisory Board Co. Value Analysis (NASDAQ:ABCO) : January 10, 2017
Jan-09-17 07:17AM  The Advisory Board Co. breached its 50 day moving average in a Bullish Manner : ABCO-US : January 9, 2017
Jan-06-17 10:02PM  Urban Institute to get 10 years of tax rebates after move to L'Enfant Plaza at bizjournals.com +6.44%
Jan-04-17 06:03AM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or Di
Jan-03-17 04:50PM  The Advisory Board Company Aligns Health Care Capabilities to Enhance Efficiency and Drive Future Growth PR Newswire
Dec-21-16 05:00AM  Employers, Educators, Policymakers Collaborate to Outline Pathway to Middle Class through Health Care Careers PR Newswire
Dec-13-16 05:29PM  How D.C.'s West End stands to be impacted by Obama's post-presidency office plans at bizjournals.com
11:06AM  ETFs with exposure to The Advisory Board Co. : December 13, 2016
Dec-12-16 12:49PM  Hedge Funds Are Dumping The Advisory Board Company (ABCO) at Insider Monkey
09:20AM  Partnerships among Hospitals, Public Agencies, and Community-Based Organizations Can Improve Public Health PR Newswire
Nov-22-16 11:00AM  The Advisory Board Company to Participate in the Piper Jaffray Healthcare Conference on November 30, 2016 PR Newswire
Nov-18-16 12:54PM  ETFs with exposure to The Advisory Board Co. : November 18, 2016
Nov-17-16 12:41PM  Advisory Board Helps Hospitals, Health Systems Achieve more than $1.5 Billion ROI PR Newswire
10:37AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016
10:00AM  The Advisory Board Company (Nasdaq: ABCO) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
Nov-09-16 04:29PM  ADVISORY BOARD CO Files SEC form 10-Q, Quarterly Report
Nov-02-16 09:41AM  Four Universities Honored with National Awards for Advances in Student Success PR Newswire -8.19%
12:03AM  Edited Transcript of ABCO earnings conference call or presentation 1-Nov-16 9:30pm GMT
Nov-01-16 05:07PM  Advisory Board misses Street 3Q forecasts
05:04PM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:10PM  The Advisory Board Company Reports Third Quarter Results PR Newswire
09:40AM  Top College Students Who Lose Small Amounts of Financial Aid More Likely to Drop Out PR Newswire
07:07AM  Q3 2016 Advisory Board Co Earnings Release - After Market Close
Oct-31-16 09:40AM  Medical Service Stock Earnings on Nov 1: ABCO, EVHC, HWAY
Oct-24-16 08:44AM  The Advisory Board Co. breached its 50 day moving average in a Bearish Manner : ABCO-US : October 24, 2016
Oct-19-16 12:31PM  The incentive war: How Marriott's new deal stacks up at bizjournals.com
Oct-11-16 12:00PM  The Advisory Board Company to Report Third Quarter Financial Results After Market Close on November 1, 2016 PR Newswire
Oct-10-16 10:17AM  The Advisory Board Co. Value Analysis (NASDAQ:ABCO) : October 10, 2016
Oct-07-16 08:08AM  The Advisory Board Co. breached its 50 day moving average in a Bullish Manner : ABCO-US : October 7, 2016
Sep-22-16 05:19PM  American CEOs sound off: What they would tell the next prez at bizjournals.com
Sep-16-16 10:09AM  Masimo PVI: Efficient Predictor for Fluid Optimization
Sep-13-16 04:15PM  The Advisory Board Company to Host Analyst and Investor Day September 26, 2016 PR Newswire
08:53AM  5 Medical Services Stocks to Buy Amid Healthcare Anxiety
08:15AM  NovoCure (NVCR) Worth Watching: Stock Jumps 6.6% in Session
Sep-08-16 01:34PM  The Advisory Board Company to Participate in Upcoming Conferences PR Newswire
Sep-07-16 10:21AM  HCA Holdings Boosts Patient Care; to Buy Mobile Heartbeat
Aug-29-16 04:03PM  The Advisory Board Company to Participate in Upcoming Conferences PR Newswire
09:26AM  INC Research Upgraded to Strong Buy on Estimate Revision
Aug-22-16 09:30AM  Zacks.com featured highlights: Coty, Advisory Board, Pan American Silver, Royal Gold and Cirrus Logic
Aug-19-16 09:57AM  5 Low Beta Stocks to Endure a Volatile Market
Aug-16-16 10:18AM  Why Civitas Solutions (CIVI) Could Be Positioned for a Slump
08:30AM  Strength Seen in Healthways Inc (HWAY): Stock Goes Up 7%
Aug-09-16 04:20PM  ADVISORY BOARD CO Files SEC form 10-Q, Quarterly Report
Aug-08-16 01:45PM  ETFs with exposure to The Advisory Board Co. : August 8, 2016
09:12AM  PAREXEL International (PRXL) Q4 Earnings Beat, Up Y/Y
Aug-05-16 10:38AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
Aug-03-16 02:56PM  Community Health (CYH) Lags Q2 Earnings, Stock Plunges
Aug-02-16 09:34AM  Will Advisory Board (ABCO) Continue to Surge Higher?
Jul-28-16 01:39AM  Edited Transcript of ABCO earnings conference call or presentation 27-Jul-16 9:30pm GMT +11.75%
Jul-27-16 04:46PM  Advisory Board beats Street 2Q forecasts
The Advisory Board Company provides best practices research and insight, technology, consulting and management, and data-enabled services in the United States and internationally. Its best practices research and insight programs include published studies, executive education, proprietary databases and online services, access to experts, executive briefings, and other services. The company's best practices research and insight programs are focused on understanding industry dynamics, identifying best-demonstrated management practices, critically evaluating widely-followed but ineffective practices, and analyzing emerging trends within the health care and education industries. It also offers cloud-based software applications that allow members to combine insights derived from best practices research with their operational and financial data and third-party and proprietary data to benchmark performance; identify and assess revenue, cost, quality, and performance improvement opportunities; and implement identified best practices. In addition, the company provides consulting services that provide on-the-ground support for performance improvement initiatives, as well as best practice professional management of the hospital or medical group areas. Further, it offers data-driven solutions by supporting colleges and universities in targeting qualified prospective students; building relationships with prospective students; and optimizing financial aid resources, as well as strategic, data-driven student engagement, and enrollment management solutions. The provides its services through discrete programs to hospitals, health systems, independent medical groups, pharmaceutical and biotechnology companies, health care insurers, medical device companies, colleges, universities, and other health care-focused organizations and educational institutions. The Advisory Board Company was founded in 1979 and is headquartered in Washington, District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miller Cormac FChief Product OfficerApr 19Option Exercise16.5875012,43521,503Apr 20 05:00 PM
Miller Cormac FChief Product OfficerApr 19Sale47.3775035,52820,753Apr 20 05:00 PM
FELSENTHAL DAVID LPresidentApr 18Option Exercise0.005,397064,547Apr 20 04:30 PM
Farber Evan RChief Legal OfficerApr 18Option Exercise0.001,22202,610Apr 20 04:33 PM
Kirshbaum Michael TChief Financial OfficerApr 18Option Exercise0.001,974047,168Apr 20 04:36 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 18Option Exercise0.001,833018,958Apr 20 04:47 PM
VAN HOOSE MARYChief Talent OfficerApr 18Option Exercise0.001,833039,084Apr 20 04:50 PM
Musslewhite Robert WChief Executive OfficerApr 18Option Exercise0.008,5540274,843Apr 20 04:55 PM
Miller Cormac FChief Product OfficerApr 18Option Exercise0.001,833021,360Apr 20 05:00 PM
Miller Cormac FChief Product OfficerApr 18Option Exercise0.0031104,703Apr 20 05:00 PM
Miller Cormac FChief Product OfficerApr 12Option Exercise16.5875012,43520,277Apr 13 05:08 PM
Miller Cormac FChief Product OfficerApr 12Sale47.2075035,40019,527Apr 13 05:08 PM
Kirshbaum Michael TChief Financial OfficerApr 11Option Exercise0.001,641045,790Apr 12 09:49 PM
Farber Evan RChief Legal OfficerApr 11Option Exercise0.001,08901,749Apr 12 09:55 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 11Option Exercise0.001,478017,613Apr 12 09:55 PM
VAN HOOSE MARYChief Talent OfficerApr 11Option Exercise0.001,459037,734Apr 12 09:59 PM
FELSENTHAL DAVID LPresidentApr 11Option Exercise0.004,377060,560Apr 12 09:58 PM
Musslewhite Robert WChief Executive OfficerApr 11Option Exercise0.006,8480268,714Apr 12 09:33 PM
Miller Cormac FChief Product OfficerApr 11Option Exercise0.001,491020,008Apr 13 05:08 PM
Musslewhite Robert WChief Executive OfficerApr 10Option Exercise32.7855,9841,835,122297,719Apr 12 09:33 PM
FELSENTHAL DAVID LPresidentApr 10Option Exercise0.004,128057,384Apr 12 09:58 PM
VAN HOOSE MARYChief Talent OfficerApr 10Option Exercise0.001,329036,715Apr 12 09:59 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 10Option Exercise37.1010,023371,85424,187Apr 12 09:55 PM
Farber Evan RChief Legal OfficerApr 10Option Exercise0.009830983Apr 12 09:55 PM
Kirshbaum Michael TChief Financial OfficerApr 10Option Exercise36.6610,297377,46452,337Apr 12 09:49 PM
Miller Cormac FChief Product OfficerApr 10Option Exercise0.001,541019,028Apr 13 05:08 PM
Miller Cormac FChief Product OfficerApr 10Option Exercise0.0037904,575Apr 13 05:08 PM
Musslewhite Robert WChief Executive OfficerApr 10Sale47.4811,000522,251261,866Apr 12 09:33 PM
Miller Cormac FChief Product OfficerApr 05Option Exercise16.5875012,43518,237Apr 07 07:07 PM
Miller Cormac FChief Product OfficerApr 05Sale46.7075035,02517,487Apr 07 07:07 PM
FELSENTHAL DAVID LPresidentApr 03Option Exercise43.8312,020526,83765,276Apr 04 09:58 PM
FELSENTHAL DAVID LPresidentApr 03Sale46.8412,020562,98453,256Apr 04 09:58 PM
Miller Cormac FChief Product OfficerApr 02Option Exercise0.0079804,462Apr 04 09:48 PM
Farber Evan RChief Legal OfficerMar 24Option Exercise43.835,656247,9025,656Mar 28 02:59 PM
FELSENTHAL DAVID LPresidentMar 24Option Exercise43.8312,020526,83765,276Mar 28 03:44 PM
FELSENTHAL DAVID LPresidentMar 24Sale47.0012,020564,94053,256Mar 28 03:44 PM
Farber Evan RChief Legal OfficerMar 24Sale48.005,656271,4880Mar 28 02:59 PM
FELSENTHAL DAVID LPresidentMar 16Option Exercise16.5832,000530,56085,256Mar 20 05:44 PM
Miller Cormac FChief Product OfficerMar 16Option Exercise16.588,160135,29325,647Mar 20 06:08 PM
Miller Cormac FChief Product OfficerMar 16Sale44.838,160365,81317,487Mar 20 06:08 PM
FELSENTHAL DAVID LPresidentMar 16Sale45.0132,0001,440,32053,256Mar 20 05:44 PM
Miller Cormac FChief Product OfficerMar 01Option Exercise16.5875012,43518,237Mar 03 09:04 AM
Miller Cormac FChief Product OfficerMar 01Sale45.1675033,87017,487Mar 03 09:04 AM
Miller Cormac FChief Product OfficerFeb 15Option Exercise16.5875012,43518,237Feb 17 01:46 PM
Miller Cormac FChief Product OfficerFeb 15Sale47.5075035,62517,487Feb 17 01:46 PM
Musslewhite Robert WChief Executive OfficerFeb 13Option Exercise16.585,50091,190260,811Feb 15 05:06 PM
Musslewhite Robert WChief Executive OfficerFeb 13Sale47.245,500259,820255,311Feb 15 05:06 PM
VAN HOOSE MARYChief Talent OfficerFeb 07Option Exercise43.838,484371,85443,870Feb 08 08:50 PM
VAN HOOSE MARYChief Talent OfficerFeb 07Sale46.848,484397,39135,386Feb 08 08:50 PM
Miller Cormac FChief Product OfficerFeb 01Option Exercise16.5875012,43518,237Feb 03 11:54 AM
Miller Cormac FChief Product OfficerFeb 01Sale45.8975034,41817,487Feb 03 11:54 AM
VAN HOOSE MARYChief Talent OfficerJan 19Option Exercise16.582,00033,16037,386Jan 20 04:57 PM
VAN HOOSE MARYChief Talent OfficerJan 19Sale41.442,00082,88035,386Jan 20 04:57 PM
Miller Cormac FChief Product OfficerJan 18Option Exercise16.5875012,43518,237Jan 20 11:46 AM
Miller Cormac FChief Product OfficerJan 18Sale40.5375030,39817,487Jan 20 11:46 AM
Musslewhite Robert WChief Executive OfficerJan 09Option Exercise16.585,50091,190260,811Jan 11 05:02 PM
Musslewhite Robert WChief Executive OfficerJan 09Sale35.765,500196,680255,311Jan 11 05:02 PM
Miller Cormac FChief Product OfficerJan 04Option Exercise16.5875012,43518,237Jan 09 06:01 AM
Miller Cormac FChief Product OfficerJan 04Sale32.6875024,50717,487Jan 09 06:01 AM
VAN HOOSE MARYChief Talent OfficerJan 03Option Exercise16.582,00033,16037,386Jan 04 10:39 AM
VAN HOOSE MARYChief Talent OfficerJan 03Sale33.492,00066,98035,386Jan 04 10:39 AM
Miller Cormac FChief Product OfficerDec 20Option Exercise16.5875012,43518,237Dec 22 07:35 PM
Kirshbaum Michael TChief Financial OfficerDec 20Option Exercise16.582,40039,79245,503Dec 22 07:51 PM
Kirshbaum Michael TChief Financial OfficerDec 20Sale32.922,40079,00843,103Dec 22 07:51 PM
Miller Cormac FChief Product OfficerDec 20Sale32.8575024,63817,487Dec 22 07:35 PM
VAN HOOSE MARYChief Talent OfficerDec 19Option Exercise16.582,00033,16037,386Dec 21 06:15 PM
VAN HOOSE MARYChief Talent OfficerDec 19Sale32.482,00064,96035,386Dec 21 06:15 PM
Musslewhite Robert WChief Executive OfficerDec 12Option Exercise16.585,50091,190259,084Dec 14 07:24 PM
Musslewhite Robert WChief Executive OfficerDec 12Sale33.875,500186,298255,311Dec 14 07:24 PM
Miller Cormac FChief Product OfficerDec 07Option Exercise16.5875012,43518,237Dec 09 08:39 AM
Miller Cormac FChief Product OfficerDec 07Sale32.5875024,43517,487Dec 09 08:39 AM
VAN HOOSE MARYChief Talent OfficerDec 06Option Exercise16.582,00033,16037,386Dec 08 08:04 PM
VAN HOOSE MARYChief Talent OfficerDec 06Sale31.982,00063,96035,386Dec 08 08:04 PM
Miller Cormac FChief Product OfficerNov 23Option Exercise16.5875012,43518,237Nov 29 10:25 AM
Miller Cormac FChief Product OfficerNov 23Sale36.7075027,52517,487Nov 29 10:25 AM
VAN HOOSE MARYChief Talent OfficerNov 22Option Exercise16.582,00033,16037,386Nov 23 12:44 PM
VAN HOOSE MARYChief Talent OfficerNov 22Sale36.982,00073,96035,386Nov 23 12:44 PM
Kirshbaum Michael TChief Financial OfficerNov 21Option Exercise16.582,40039,79245,503Nov 23 12:27 PM
Kirshbaum Michael TChief Financial OfficerNov 21Sale36.052,40086,52043,103Nov 23 12:27 PM
Musslewhite Robert WChief Executive OfficerNov 14Option Exercise16.585,50091,190260,811Nov 16 12:57 PM
Musslewhite Robert WChief Executive OfficerNov 14Sale32.885,500180,840255,311Nov 16 12:57 PM
VAN HOOSE MARYChief Talent OfficerNov 10Option Exercise16.582,00033,16037,386Nov 10 09:13 PM
VAN HOOSE MARYChief Talent OfficerNov 10Sale34.262,00068,52035,386Nov 10 09:13 PM
Miller Cormac FChief Product OfficerNov 09Option Exercise16.5875012,43518,237Nov 10 05:09 PM
Miller Cormac FChief Product OfficerNov 09Sale34.6375025,97317,487Nov 10 05:09 PM
Miller Cormac FChief Product OfficerOct 26Option Exercise16.5875012,43518,237Oct 28 01:15 PM
Miller Cormac FChief Product OfficerOct 26Sale41.6375031,22317,487Oct 28 01:15 PM
Kirshbaum Michael TChief Financial OfficerOct 20Option Exercise16.582,40039,79245,503Oct 24 09:20 PM
Kirshbaum Michael TChief Financial OfficerOct 20Sale42.802,400102,72043,103Oct 24 09:20 PM
Miller Cormac FChief Product OfficerOct 12Option Exercise16.5875012,43518,237Oct 14 03:49 PM
Miller Cormac FChief Product OfficerOct 12Sale43.1575032,36317,487Oct 14 03:49 PM
Musslewhite Robert WChief Executive OfficerOct 10Option Exercise16.585,50091,190260,811Oct 12 05:04 PM
Musslewhite Robert WChief Executive OfficerOct 10Sale43.895,500241,395255,311Oct 12 05:04 PM
ADVISORY BOARD CO10% OwnerSep 22Sale22.50317,7127,148,5204,128,167Sep 22 03:05 PM
Kirshbaum Michael TChief Financial OfficerSep 20Option Exercise16.582,40039,79245,503Sep 22 02:11 PM
Kirshbaum Michael TChief Financial OfficerSep 20Sale43.012,400103,22443,103Sep 22 02:11 PM
Miller Cormac FChief Product OfficerSep 14Option Exercise16.581,50024,87018,987Sep 16 04:36 PM
Miller Cormac FChief Product OfficerSep 14Sale43.041,50064,56017,487Sep 16 04:36 PM
ADVISORY BOARD CO10% OwnerSep 14Sale22.501,936,52943,571,9034,445,879Sep 14 05:00 PM
Musslewhite Robert WChief Executive OfficerSep 12Option Exercise16.585,50091,190260,811Sep 14 04:41 PM